Thalidomide Litigation — Grünenthal Intimidation — Landmark Settlement

1967-1968: Grünenthal executives were put on trial in Aachen, Germany The indictment charged the company with intent to commit bodily harm and involuntary manslaughter.  The central defendant was Dr. Heinrich Mückter, an indicted Nazi war criminal, who was the company’s chief scientist . . . Continue reading →

“From the Holocaust to Thalidomide: A Nazi Legacy”

“How Men Who Blighted Lives of thousands Evaded Justice.” The post-WWII horror story of thalidomide begins in the picture-book town of Stolberg, near Aachen, in western Germany, with the establishment of Chemie Grünenthal, a Wirtz family-owned pharmaceutical company. After WWII, Nazi scientists stared . . . Continue reading →

TeenScreen Operations Have Shut Down

teenscreen-not-lab-rat.jpg

   The following announcement was posted on TeenScreen’s website (November 15, 2012):  "Important Announcement for Schools & Communities:  We are sorry to inform you that the TeenScreen National Center will be winding down its program at the end of this year. Accordingly, . . . Continue reading →

America’s Healthcare Crisis–Part II–What Do We Get for $$$ ?

burger_pills.jpg

Part II.  What Do We Get for All That Money?  A preventable epidemic of injury and death from prescription drugs; FDA’s contribution to the epidemic;  Big Pharma’s business model: manufactured myths, propaganda and a hidden agenda;

Continue reading →

How FDA Facilitated the Cost of a Drug to Skyrocket

The FDA granted market exclusivity to KV for an old drug that had been available from special pharmacies that custom-compound treatments not approved by the FDA, for $20 a shot. By granting KV market exclusivity, women could no longer obtain the drug, Makena, at a reasonable price– KV set the price at $1,500 a shot. Continue reading →